BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32725498)

  • 1. Types of M protein and clinicopathological profiles in patients with monoclonal gammopathy of renal significance.
    Liang D; Liu J; Liang S; Xu F; Cheng Z; Huang X; Zeng C; Liu Z
    J Nephrol; 2021 Aug; 34(4):1137-1146. PubMed ID: 32725498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
    Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
    Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic characteristics and prognostic analysis of monoclonal gammopathy of renal significance (MGRS) in patients with IgM monoclonal gammopathy: a case series.
    Liu J; Liang D; Liang S; Xu F; Huang X; Jiang S; Hou J
    Sci Rep; 2022 Oct; 12(1):16994. PubMed ID: 36216844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunofluorescence staining for immunoglobulin heavy chain/light chain on kidney biopsies is a valuable ancillary technique for the diagnosis of monoclonal gammopathy-associated kidney diseases.
    Nasr SH; Fidler ME; Said SM; Koepplin JW; Altamirano-Alonso JM; Leung N
    Kidney Int; 2021 Jul; 100(1):155-170. PubMed ID: 33774084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy.
    Klomjit N; Leung N; Fervenza F; Sethi S; Zand L
    J Am Soc Nephrol; 2020 Oct; 31(10):2400-2411. PubMed ID: 32747354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
    Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
    Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review.
    Yu XJ; Zhou XJ; Wang SX; Zhou FD; Zhao MH
    BMC Nephrol; 2018 Nov; 19(1):322. PubMed ID: 30419839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
    Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
    Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical characteristics and outcome of monoclonal gammopathy of renal significance-related lesions in Latin America.
    Peña C; Schutz NP; Riva E; Valjalo R; Majlis A; López-Vidal H; Lois V; Zamora D; Ochoa P; Shanley C; Gonzalez JT; Fantl D; Correa G; Ramirez J; Mur P; Silva G; Verri V; Rojas C; Escobar K; Glavic G; Méndez GP;
    Nephrology (Carlton); 2020 Jun; 25(6):442-449. PubMed ID: 31825549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired Fanconi syndrome secondary to light chain deposition disease associated with monoclonal gammopathy of renal significance: A case report.
    Tu H; Mou L; Zhu L; Jiang Q; Gao DS; Hu Y
    Medicine (Baltimore); 2018 Sep; 97(36):e12027. PubMed ID: 30200082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
    Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
    Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
    Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
    [No Abstract]   [Full Text] [Related]  

  • 13. DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients.
    Said SM; Leung N; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera LH; Sethi S; Zhang P; Nasr SH
    Kidney Int; 2020 Aug; 98(2):498-504. PubMed ID: 32622524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review.
    Huang J; Sun C; Su H; Zhang C; Xiong J
    Kidney Blood Press Res; 2019; 44(4):858-869. PubMed ID: 31352451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy].
    Lu H; Zhang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS).
    Niculae A; Peride I; Vinereanu V; Rădulescu D; Bratu OG; Geavlete BF; ChecheriŢă IA
    Rom J Morphol Embryol; 2017; 58(3):1065-1068. PubMed ID: 29250691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance.
    Gomes-Alves I; Castro-Ferreira I
    Acta Med Port; 2021 May; 34(5):372-377. PubMed ID: 33819437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of monoclonal gammopathy of renal significance.
    Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
    Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of the clinical features of MGRS.
    Du J; Hu Z
    BMC Nephrol; 2024 Jan; 25(1):22. PubMed ID: 38229028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.